ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 232 filers reported holding ARGENX SE in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,188,000 | -86.9% | 17,527 | -86.0% | 0.18% | -88.8% |
| Q2 2022 | $47,360,000 | +20.2% | 125,000 | 0.0% | 1.64% | +32.6% |
| Q1 2022 | $39,414,000 | +21.5% | 125,000 | -38.2% | 1.23% | -57.8% |
| Q4 2019 | $32,444,000 | -46.4% | 202,117 | -61.9% | 2.92% | -61.7% |
| Q3 2019 | $60,532,000 | -26.4% | 531,165 | -8.6% | 7.64% | -8.1% |
| Q2 2019 | $82,281,000 | -20.1% | 581,165 | -29.6% | 8.31% | -12.4% |
| Q1 2019 | $103,004,000 | +29.9% | 825,087 | 0.0% | 9.50% | +19.7% |
| Q4 2018 | $79,266,000 | – | 825,087 | – | 7.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |